CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON) has a 9-report earnings history dating back to May 09, 2024. Its average absolute post-earnings move is ±4.81%, and 55.6% of those reactions were positive. Its largest post-earnings gain was +8.61% (Nov 14, 2025) and its largest decline was -7.43% (May 09, 2024). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±4.81%
Positive %
55.6%
Negative %
44.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 08, 2026 | ☀ PRE | $69.31 | $70.27 | $69.67 | 50,889 | +0.74% | open_in_new |
| Feb 27, 2026 | ☀ PRE | $55.79 | $59.77 | $58.80 | 1,062,900 | +4.79% | open_in_new |
| Nov 14, 2025 | ☀ PRE | $38.02 | $41.73 | $41.01 | 1,408,600 | +8.61% | open_in_new |
| Aug 08, 2025 | ☀ PRE | $24.51 | $25.07 | $24.85 | 672,700 | +2.05% | open_in_new |
| May 13, 2025 | ☀ PRE | $24.21 | $25.58 | $24.18 | 884,800 | -3.9% | open_in_new |
| Mar 28, 2025 | ☀ PRE | $26.63 | $26.77 | $26.42 | 729,100 | -1.93% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $39.68 | $39.80 | $36.98 | 528,400 | -6.83% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $31.02 | $33.53 | $33.24 | 360,400 | +7.02% | open_in_new |
| May 09, 2024 | ☀ PRE | $32.89 | $33.32 | $30.02 | 694,100 | -7.43% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±4.81%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260608 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
| 8-K | 20260526 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
Frequently asked about CGON earnings
When does CG Oncology, Inc. report earnings next? expand_more
CG Oncology, Inc. (CGON)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CGON stock move after earnings? expand_more
Over 9 reports, CGON has moved an average of ±4.81% the session after earnings, closing higher 55.6% of the time.
What was CGON's biggest post-earnings move? expand_more
CGON's largest post-earnings gain on record was +8.61% on Nov 14, 2025, and its largest decline was -7.43% on May 09, 2024.
Where can I find CG Oncology, Inc.'s SEC filings? expand_more
All of CG Oncology, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right